Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMG as Addition to Luteal Phase Support in ICSI Cycles
NCT03209687Phase 4Completed
- Sponsor
- Cairo University
- Start
- Jul 2017
- Primary completion
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of menotropins in infertility (2 arms), sponsored by Cairo University. Primary endpoint: Live birth rate at 2 years. Started Jul 2017; status: completed.
02
Drugs
menotropins
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03209687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03209687.